Introduction:
Welded Gabion is also named gabions, rock gabions, welded wire gabions, welded mesh gabions, gabion boxes, gabion mattresses, gabion basket, galfan coated welded gabions, welded mesh gabion box. It is composed of welded mesh panel and spring steel lacing wire.
Gabion Box Wire Materials:
Gabion Box is manufactured in Electro Galvanized Iron Wire; Hot Dipped Galvanized Iron Wire; Heavy Galvanized Iron Wire; Or PVC Coated Wire or Stainless Steel Wire.
Sepcification of Gabions:
Application:
1. Control and guide of water or flood
2. Preventing of rock breaking
3. Rock fall protection
4. Water and soil protection
5. Bridge protection
6. Strengthening structure of soil
7. Protection engineering of seaside area.
8. Port project
9. Keep off dust wall
10. Roadway protection.
Features:
1Economic. Just fill the stone into the gabions and seal it.
2. Simple installation. No special technology needed.
3. Weather proof under natural destroy, corrosion resistant.
4. Sludge in the stones is good for plant growing. Mixed to form a integrity with the natural environment.
5. Good permeation can prevent the damage by hydrostatic.
6. Less transport freight. It can be folded together for transport and further installation.
7. No collapse even under big scope of deforming.
Packaging:
1. Water-proof paper inside and wrap with plastic film outside;
2. Pallet packing;
3. According to your requirements.
Delivery: 7-15 days
Â
|
Length (m) |
width (m) |
height (m) |
diaphragm |
volume |
tolerance |
|
2 |
1 |
0.3 |
1 |
0.6 |
Length+/-3% Width+/-5% Height+/-5% |
|
3 |
1 |
0.3 |
2 |
0.9 |
|
|
4 |
1 |
0.3 |
3 |
1.2 |
|
|
2 |
1 |
0.5 |
1 |
1 |
|
|
3 |
1 |
0.5 |
2 |
1.5 |
|
|
4 |
1 |
0.5 |
3 |
2 |
|
|
1 |
1 |
0.5 |
0 |
1 |
|
|
1.5 |
1 |
1 |
0 |
1.5 |
|
|
2 |
1 |
1 |
1 |
2 |
|
|
3 |
1 |
1 |
2 |
3 |
|
|
4 |
1 |
1 |
3 |
4 |
EGFR Inhibitors is widely used and the most successful in the treatment of non-small cell lung cancer (NSCLC), Currently EGFR drugs are sensitive to EGFR gene mutations in non-small cell lung cancer have efficiency more than 70% on the market. However, almost all patients occurs drug resistance. For resistance to EGFR inhibitors, there is no standard treatment at moment. AZD9291 will become a tool to overcome this problem. Another similar drug CO-1686 is in the same development stage. 60% of Resistance reason is that EGFR gene has a new mutation: T790M mutation. These two new drugs play a role in the site of the T790M mutation. Compared with the prior Egfr Inhibitor, it has low side effect of skin rashes, diarrhea and other side effects,it indicated that AZD9291 has more stronger selective on tumor cell. while it also has slight inhibit of normal tissues of normal organs. ADZ9291 has not found dose-limiting toxicity. All patients have been fully recovered and continues to be regularly reviewed. In clinical practice, if the first EGFR inhibitors occur resistance, the primary physicians use some selective, mild side effects of three generations of drugs, not guide by detecting T790M, there may be open a convenience door asap. The next study is to explore the feasibility of AZD9291 and CO-1686 from the second line treatment into the first -line treatment drug. If enter the front-line clinical, the price of the existing first-line drugs is expected to significantly cut. Looking to the future, these indications of new drugs should be clear to lung cancer Tpatients of 790M mutation, but the main problem is the existing tumor tissue biopsy and re-biopsy again. it will face some challenges in clinical practice . Fortunately, these new methods are currently being developed mutation status can be detected from the plasma of patients, it is estimated to push the clinic 2 years later.
Conbottpharm could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Egfr Inhibitor,Selective Egfr Inhibitor,Potent Egfr Inhibitor Afatinib
Conbott Pharmtech Co.,Ltd. , http://www.conbottpharm.com